Sai Parenterals Announces 25th AGM on September 10, 2026

Sai Parenterals Ltd has announced its 25th Annual General Meeting (AGM) for the Financial Year 2025-26, scheduled for September 10, 2026, at 11:00 AM via Video Conference. The company has complied with SEBI (LODR) Regulations, 2015, by submitting the AGM notice. The annual report, dispatched on August 19, 2026, is available on the company's website. The report highlights the company's evolution into an integrated pharmaceutical platform with a strong foundation in branded generics and a growing CDMO business. Investments in R&D and manufacturing capabilities, including a network of five facilities with significant capacity, are aimed at expanding into regulated markets and advancing its injectables portfolio. The company also notes its international presence through Noumed and a renewed OTC medicines supply agreement in Australia.